The 3rd International Electronic Conference on Biomedicines
ECB 2025 Closed.
ECB 2027 Conference is Now OPEN for Abstract Submission and Registration.
Submit your abstracts HERE.
Instructions for authors are available online.
For any inquiries, please contact us at ecb@mdpi.com.
the chairs
Dear colleagues,
It is a great pleasure to welcome you to the 3rd International Electronic Conference on Biomedicines (ECB 2025), which will be held from 12 to 15 May 2025. This electronic conference will be held online at https://sciforum.net/event/ECB2025.
The goal of this conference is to enable scientists to present their latest research in the field of biomedicines and engage in discussions with the scientific community worldwide. Recent advances in biomedical research have provided an advanced insight into the biological background of human disease, setting the groundwork for the development of new therapeutic strategies. This conference aims to connect scientists working on this field of research from across the globe, allowing them to exchange ideas on the discovery and characterization of new therapeutic targets in the era of precise medicine.
The agenda of the conference includes, but is not limited to, the following topics:
S1. Insulin Resistance or Hyperinsulinemia
S2. Immunotherapy and Adverse Effects
S3. Tumor Microenvironment
S4. Immune System, Tumor Immunology and Autoimmune Disease
S5. Biomedicine in Cardiovascular Diseases
S6. Diabetes, Obesity and Metabolic Diseases
S7. Gene Therapy and Gene Editing
S8. Rare Diseases
S9. Molecular Mechanisms of Neurodegeneration
The ECB 2025 will be an online-only event, enabling scientists from all over the world to participate, with a small registration fee, but with no requirement for travel or related expenses. The electronic form of the conference provides a platform for rapid and direct exchanges regarding the latest research findings and novel ideas.
All participants are encouraged to submit an extended full manuscript for potential publication in the Biomedicines journal (ISSN: 2227-9059), with a 20% discount on the publication fee. All submitted papers will undergo MDPI’s standard peer-review procedure.
We look forward to receiving your contributions to this scientific event, and we would like to thank you in advance for your support.
Conference chairs
Prof. Dr. Felipe Fregni,
Prof. Dr. Allan Stensballe,
Prof. Dr. Georgia Levidou,
Prof. Dr. Serafino Fazio
Follow the conference organizer on Social Media
Meet the Event Chairs
Important Dates
- Abstract submission deadlineFeb 10, 2025
- Abstract acceptance notificationMar 10, 2025
- Registration end dateMay 08, 2025
Meet Our Speakers
Prof. Michele Ammendola
Department of Health Science, University “Magna Graecia” Medical School, Digestive Surgery Unit, "Renato Dulbecco" Hospital, Viale Europa, Germaneto, 88100 Catanzaro, Italy;
Prof. Michele Ammendola is an Associate Professor of General Surgery. Author of many scientific articles published in international journals with international collaborations. Member of International Scientific Societies. His ongoing research interests involve the study of tumor microenvironment, particularly analyzing the role of immune stromal cells in neoangiogenesis of gastrointestinal solid tumors (Study of the mechanisms of remodeling of the tumor microenvironment in colorectal tumors, Principal Investigator in the PRIN 2022 2022CMTZNH project).
Dr. Daniel de Vicente
President of ASMD Spain (Patients Association), Board member of FEDER (Spanish Federation of Rare Diseases), Board member of Eurordis (Rare Diseases Europe);
Prof. Dr. Alexander V. Ljubimov
Cedars-Sinai Medical Center & UCLA, Los Angeles, CA, USA;
Professor Ljubimov is Director of the Division of Applied Cell Biology and Physiology, Department of Biomedical Sciences, and Director of the Board of Governors Regenerative Medicine Institute Eye Program at Cedars-Sinai Medical Center, and Professor of Medicine at UCLA. He is an internationally known cancer and ocular diabetes researcher. He authored over 140 publications and is on 15 Editorial Boards. He is Gold Fellow of the Association for Research in Vision and Ophthalmology and Overseas Fellow of the Royal Society of Medicine.
- S1. Insulin Resistance or Hyperinsulinemia
- S2. Immunotherapy and Adverse Effects
- S3. Tumor Microenvironment
- S4. Immune System, Tumor Immunology and Autoimmune Disease
- S5. Biomedicine in Cardiovascular Diseases
Sponsors and Partners
Organizer
Co-organizer
Media partner
On behalf of the chairs of the ECB2025 Conference, we are pleased to announce the selected winners of the Best Oral Presentation Awards and Best Poster Awards.
The Best Oral Presentation Awards have been awarded to
The Best Poster Awards have been awarded to
Congratulations!
Your ECB2025 Organizing team
ecb@mdpi.com
Day 1
Session 2. Immunotherapy and Adverse Effects
Session 7. Gene Therapy and Gene Editing
Session 4. Immune System, Tumor Immunology and Autoimmune Disease
Day 2
Session 5. Biomedicine in Cardiovascular Diseases
Session 3. Tumor Microenvironment
Day 3
Session 9. Molecular Mechanisms of Neurodegeneration
S1. Insulin Resistance or Hyperinsulinemia
S6. Diabetes, Obesity and Metabolic Diseases
S8. Rare Diseases
Day 4
Flash Poster Session
Ms. Yachne Yu
Ms. Alethea Liu
Ms. Suriwipa Chuachaina
Email: ecb@mdpi.com
For inquiries regarding submissions and sponsorship opportunities, please feel free to contact us.